Evidence map›Paper›PMID 38052493›Full record

ArticleNeurology2023

Association Between Diseases and Symptoms Diagnosed in Primary Care and the Subsequent Specific Risk of Multiple Sclerosis.

Octave Guinebretiere, Thomas Nedelec, Laurene Gantzer, Beranger Lekens, Stanley Durrleman, Celine Louapre

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Multiple sclerosis: 2024 update.Free neuropathology · 2025
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Octave GuinebretiereFrom the Sorbonne Université (O.G., T.N., S.D., C.L.), Paris Brain Institute-ICM, Inserm, CNRS, Inria; Cegedim R&D (L.G., B.B.L.), Boulogne-Billancourt; and Department of Neurology (C.L.), CIC Neurosciences, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.ORCID 0009-0005-1876-2948
Thomas NedelecFrom the Sorbonne Université (O.G., T.N., S.D., C.L.), Paris Brain Institute-ICM, Inserm, CNRS, Inria; Cegedim R&D (L.G., B.B.L.), Boulogne-Billancourt; and Department of Neurology (C.L.), CIC Neurosciences, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.ORCID 0000-0002-9310-2879
Laurene GantzerFrom the Sorbonne Université (O.G., T.N., S.D., C.L.), Paris Brain Institute-ICM, Inserm, CNRS, Inria; Cegedim R&D (L.G., B.B.L.), Boulogne-Billancourt; and Department of Neurology (C.L.), CIC Neurosciences, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.ORCID 0000-0002-9043-0826
Beranger LekensFrom the Sorbonne Université (O.G., T.N., S.D., C.L.), Paris Brain Institute-ICM, Inserm, CNRS, Inria; Cegedim R&D (L.G., B.B.L.), Boulogne-Billancourt; and Department of Neurology (C.L.), CIC Neurosciences, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.ORCID 0000-0001-8648-8796
Stanley DurrlemanFrom the Sorbonne Université (O.G., T.N., S.D., C.L.), Paris Brain Institute-ICM, Inserm, CNRS, Inria; Cegedim R&D (L.G., B.B.L.), Boulogne-Billancourt; and Department of Neurology (C.L.), CIC Neurosciences, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.ORCID 0000-0002-9450-6920
Celine LouapreFrom the Sorbonne Université (O.G., T.N., S.D., C.L.), Paris Brain Institute-ICM, Inserm, CNRS, Inria; Cegedim R&D (L.G., B.B.L.), Boulogne-Billancourt; and Department of Neurology (C.L.), CIC Neurosciences, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, France.ORCID 0000-0002-4987-1531
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesPrevious studies have reported a possible prodrome in multiple sclerosis (MS) defined by nonspecific symptoms including mood disorder or genitourinary symptoms and increased health care use detected several years before diagnosis. This study aimed to evaluate agnostically the associations between diseases and symptoms diagnosed in primary care and the risk of MS relative to controls and 2 other autoimmune inflammatory diseases with similar population characteristics, namely lupus and Crohn disease (CD).

methodsA case-control study was conducted using electronic health records from the Health Improvement Network database in the United Kingdom and France. We agnostically assessed the associations between 113 diseases and symptoms in the 5 years before and after diagnosis in patients with subsequent diagnosis of MS. Individuals with a diagnosis of MS were compared with individuals without MS and individuals with 2 other autoimmune diseases, CD and lupus.

resultsThe study population consisted of patients with MS (n = 20,174), patients without MS (n = 54,790), patients with CD (n = 30,477), and patients with lupus (n = 7,337). Twelve DISCUSSION: We identified 5 health conditions associated with subsequent MS diagnosis, which may be considered not only prodromal but also early-stage symptoms. However, these health conditions overlap with prodrome of 2 other autoimmune diseases; hence, they lack specificity to MS.

Indexed as

Autoimmune DiseasesCrohn DiseaseMultiple SclerosisCase-Control StudiesHumansPrimary Health Care

Identifiers

PMID38052493
PMCPMC10791050
OpenAlexW4389329464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.